CCT-102 or Expectant Management in Delayed Pregnancy Loss
NCT06121063 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 183
Last updated 2025-08-22
Summary
A Phase 3, multi-center clinical trial of a CCT-102 regimen or expectant management to promote uterine evacuation in first trimester non-progressing Delayed Pregnancy Loss (DPL).
Conditions
- Early Pregnancy Loss, Delayed Pregnancy Loss
Interventions
- COMBINATION_PRODUCT
-
CCT-102 A and CCT-102 B
2 day oral regimen
Sponsors & Collaborators
-
Conceptra Biosciences, LLC
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-07-21
- Primary Completion
- 2025-05-15
- Completion
- 2025-07-30
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
The Novel Immunomodulatory and Anticoagulant Therapies for Recurrent Pregnancy Loss
NCT02990403 ·Status: UNKNOWN ·Phase: PHASE4
-
Serum Concentrations of Pregnancy-associated Proteins for Assessment of Gestational Age Before Abortion
NCT04232189 ·Status: TERMINATED
-
Assessment of Early Pregnancy MAB Completion
NCT06893484 ·Status: ACTIVE_NOT_RECRUITING
-
A Follow-up of the Early Pregnancy Study Cohort.
NCT01132924 ·Status: COMPLETED
-
Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
NCT02152696 ·Status: COMPLETED ·Phase: PHASE3
-
RCT for Women With a Persisting Pregnancy of Unknown Location
NCT01800162 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Maternal and Newborn Safety Profile of Progestogens in EARLY Pregnancy
NCT05186779 ·Status: TERMINATED
-
Infection and Adverse Pregnancy Outcome
NCT02673216 ·Status: UNKNOWN
-
Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 ·Status: UNKNOWN
-
A Study Looking at Women's Experiences After a Miscarriage
NCT01223482 ·Status: UNKNOWN
-
The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase(MTHFR) Gene Polymorphisms as Risk Factors for Recurrent Miscarriage
NCT03209063 ·Status: UNKNOWN
-
EnBrace HR for Depression Treatment and Prevention in Women Trying to Conceive and Early Pregnancy
NCT02676882 ·Status: COMPLETED ·Phase: NA
-
Repeat Antenatal Corticosteroids
NCT03133104 ·Status: COMPLETED
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
Study to Evaluate the Safety of Repatha® in Pregnancy
NCT02906124 ·Status: TERMINATED
-
Non-invasive Monitoring of Miscarriage
NCT06581692 ·Status: RECRUITING
-
Promoting Fetal Movement Monitoring: Improving Birth Outcomes
NCT01844011 ·Status: COMPLETED ·Phase: NA
-
Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial
NCT02145767 ·Status: COMPLETED ·Phase: PHASE2
-
RCT on the Efficacy of Methotrexate for the Prevention of GTD
NCT01984099 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Fetal Ductus Arteriosus in Predicting Spontaneous Labour at Term
NCT03073460 ·Status: WITHDRAWN ·Phase: NA
-
Interleukin-10 Promoter-1082A/G Polymorphism and Idiopathic Recurrent Miscarriage Risk
NCT02633475 ·Status: UNKNOWN
-
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
NCT02883673 ·Status: COMPLETED ·Phase: NA
-
EVERREST Developing a Therapy for Fetal Growth Restriction
NCT02097667 ·Status: COMPLETED
-
Prevalence of Ambivalence Regarding Prenatal Testing
NCT00342069 ·Status: COMPLETED
-
Progesterone for First Trimester Vaginal Bleeding
NCT01501890 ·Status: WITHDRAWN ·Phase: NA